top of page
Image by National Cancer Institute

ISWT BioAdvisory

Enable East-West Partnership in Biotech Innovations

Global Vision, Local Execution 

Value Proposition

The West-East cross-border pharmaceutical BD&L and R&D partnerships have been exploding in recent years.

The vast Asian biotech membership from InScienceWeTrust Community (ISWT-C) provides a large, high-quality deal flow.

“MeritCRO / Mianus Capital / A HK-based Healthcare Family Office" partnership provides “best-in-class” one-stop cross-border BD solution to biotech from the U.S., China, and other territories in the world.

Our team of BD, investment, and operation experts have 80+ years of cross-border BD&L and R&D experiences in East-West collaboration space.

bottom of page